We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Fox Chase Cancer Center Adopts Nexus Copy Number and Nexus Expression

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute
BioDiscovery Inc. has announced that Fox Chase Cancer Center’s Keystone Program in Blood Cell Development and Cancer has acquired a site license for Nexus Copy Number and Nexus Expression, two companion tools designed specifically for scientists working on DNA copy number and RNA expression analysis from microarray data.

The Keystone Program researchers are using Nexus Copy Number and Nexus Expression to help identify genes involved in blood cell development and transformation. Identification of such genes is important for further enhancement in treatment of cancers of the blood as genes involved in normal development are also likely to be involved in transformation of normal blood cells into cancerous cells.

Nexus Copy Number and Nexus Expression are complementary platform independent products supporting all array platforms including Agilent, Affymetrix, Illumina, Roche NimbleGen, and custom arrays. They can integrate data from thousands of arrays in a single project and provide an easy to use interface that allows exploration of data to generate biological knowledge with a few mouse clicks. Nexus Copy Number allows analysis of CGH and SNP arrays for single or multiple sample analysis and Nexus Expression provides analysis of gene expression arrays.